Theseus Pharmaceuticals Cash Flow Statement

Financials in millions RON. Fiscal year is January - December.

Millions RON. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Net Income	254.93	251.53	-904.1	2,769	5,013	-102.98	Upgrade
Other Operating Activities	-149.32	229.53	10,719	21.5	-4,186	1,855	Upgrade
Operating Cash Flow	105.6	481.06	9,815	2,791	826.24	1,752	Upgrade
Operating Cash Flow Growth	-98.97%	-95.10%	251.66%	237.79%	-52.84%	48.82%	Upgrade
Repurchase of Common Stock	-232.74	-216.38	-1,830	-1,147	-327.03	-1,068	Upgrade
Other Financing Activities	-174.73	-181.4	-8,687	-1,146	-0.09	-0.07	Upgrade
Financing Cash Flow	-408.33	-398.63	-10,535	-2,295	-1,105	-1,463	Upgrade
Miscellaneous Cash Flow Adjustments	0	0	-	-	-	-	Upgrade
Net Cash Flow	-302.72	82.43	-720.43	496.23	-278.82	288.57	Upgrade
Levered Free Cash Flow	644.11	530.76	-832.47	2,621	2,361	-48.77	Upgrade
Unlevered Free Cash Flow	644.11	530.76	-832.42	2,621	2,361	-48.72	Upgrade
Change in Net Working Capital	-483.72	-372.36	386.45	-776.42	775.97	-7.96	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.